Position in VRTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$48,906,846
+$3,338,273 QoQ
Shares Held
109,524
+9.0% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.5761294328183777.ToString("F0")%
Shared 0.ToString("F0")%
None 99.42387056718162.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2021CallValue
$21,489
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Creative Planning holds $360,280,712 across 212 Biotechnology names. VRTX ranks #1 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
109,524 | $48,906,846 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,152 | $31,023,040 | |
| 3 | INSM |
INSMED Inc
|
72,200 | $11,806,143 | |
| 4 | EXEL |
Exelixis, Inc.
|
234,142 | $10,042,350 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
119,661 | $8,886,025 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
140,177 | $8,145,685 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,122 | $7,981,245 | |
| 8 | INCY |
Incyte Corp
|
80,874 | $7,611,860 |
All Filings in VRTX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,906,846 | 109,524 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $45,568,573 | 100,513 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $37,152,536 | 94,864 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,809,864 | 87,174 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $43,071,408 | 88,840 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $32,002,568 | 79,470 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $37,423,592 | 80,467 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $37,083,710 | 79,117 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $31,400,492 | 75,119 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $29,798,995 | 73,236 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $42,260,146 | 121,528 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $24,382,083 | 69,285 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $21,013,908 | 66,696 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,903,538 | 65,460 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,544,187 | 8,787 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $3,692,857 | 13,105 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,520,150 | 5,825 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,429,156 | 6,508 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,078,563 | 39,024 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $6,474,338 | 32,110 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $21,489 | 100 | Call | Sole | 2021-04-30 | |
| 2021-03-31 | $1,453,086 | 6,762 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $23,634 | 100 | Call | Sole | 2021-01-29 | |
| 2020-12-31 | $1,513,285 | 6,403 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,750,275 | 6,432 | Shares | Sole | 2020-11-05 | |
| 2020-09-30 | $272,120 | 1,000 | Call | Sole | 2020-11-05 | |
| 2020-06-30 | $1,150,788 | 3,964 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $702,190 | 2,951 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||